Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc.

28.49
USD
+0.83
(+3.00%)
1.69EPS
11.65P/E
858.30MMarket Cap
Mar 04Next Earn

Amphastar Pharmaceuticals, Inc. Documents

Q3 FY2025 · Quarterly report

November 6, 2025 · 308 pages

Read Amphastar Pharmaceuticals, Inc.'s results firsthand

Preview the first 2 pages of this quarterly report
Create a free account to start reading

Full documents are included with Professional

Q3 FY2025 documents